CD23 Levels on B Cells Determine Long-Term Therapeutic Response in Patients with Atopic Eczema Treated with Selective IgE Immune Apheresis

J Invest Dermatol. 2021 Mar;141(3):681-685.e6. doi: 10.1016/j.jid.2020.05.122. Epub 2020 Sep 17.
No abstract available

Publication types

  • Letter
  • Observational Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • B-Lymphocytes / immunology*
  • B-Lymphocytes / metabolism
  • Blood Component Removal
  • Dermatitis, Atopic / blood
  • Dermatitis, Atopic / immunology
  • Dermatitis, Atopic / therapy*
  • Female
  • Follow-Up Studies
  • Humans
  • Immunoglobulin E / immunology*
  • Immunoglobulin E / metabolism
  • Male
  • Middle Aged
  • Receptors, IgE / analysis*
  • Receptors, IgE / metabolism
  • Treatment Outcome
  • Young Adult

Substances

  • Receptors, IgE
  • Immunoglobulin E